Longitudinal characterisation of anti-Spike antibodies mediated functions in COVID-19 patients

Published 2022-03-22

Recommendations

Similar videos

49:52

Laura Walker: "Broadly Neutralizing Antibodies to Speed Pandemic Responses" (12/8/21)
58:37

Antibodies Against SARS-CoV-2: A Global Collaboration - Breaking News in Stem Cells
16:53

Nikolai Petrovsky: Covax19/Spikogen®; the first approved recombinant spike protein vaccine
57:50

Dr. Peter Gilbert: Immune Correlates Analysis of the mRNA-1273 Vaccine Efficacy Trial
54:57

Session III–Long Covid: What Do We Know So Far? with Dr. Carmen Scheibenbogen and Ms. Jill Jaycox
45:37

John Altin: Analysis of Antibody Response to Conserved Spike Epitopes Following COVID-19 Vaccination
05:23

How monoclonal antibody treatment works against COVID-19 infections
1:14:05

Aaron Ring: "Diverse Functional Autoantibodies in Patients with COVID-19"
54:38

Serological and Cellular Approaches to COVID-19 Research Using Flow Cytometry
1:05:11

Detecting, Dissecting, and Blocking the SARS-CoV-2 Spike | Kartik Chandran, Ph.D.
1:28:39

SARS-CoV-2 Antibody Durability
48:26

Eric Vivier - Association of COVID-19 Inflammation with Activation of the C5a-C5aR1 Axis
56:22

IMIM Seminars At Home IMIM Translational Research on COVID 19
40:54

The immunology of COVID-19: pathology and clinical implications - presented by Dr Alex Richter
1:04:25

Global Vector Hub - The impact of COVID-19 on global vector control efforts
04:15

COVID-19 Pathophysiology - Part 1: The Molecular Level
1:27:59

Mechanistic Pathways of PASC Session 1: Overview of Mechanistic Pathways
1:20:37

Management of the COVID 19 Pandemic in Europe | Full Livestream
1:03:50

Dr. Daniela Weiskopf and Dr. Alessandro Sette Lab Meeting of La Jolla Institute of Immunology
More results